NYSE: AVNS
Avanos Medical, Inc.
Healthcare · Medical - Devices
Market Cap
$1.17B
52w High
$25.49
52w Low
$9.30
P/E
-16.67
Volume
2.54M
Outstanding Shares
46.85M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 106.46% over the last year. Revenue grew 3.87% over the trailing twelve months. Operating margin moved from 7.63% to -7.92%. Free cash flow declined 93.42% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -7.92%. A decisive move in revenue — currently up 3.87% — would be the clearest signal to resolve the ambiguity.
Company profile
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
1
Buy
6
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 4, 2026
Q3 FY26 · EPS est $0.16 · Revenue est $173M
View